To include your compound in the COVID-19 Resource Center, submit it here.

IDM, Nemod cancer deal

Immuno-Designed Molecules (Paris, France) received access

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE